Institutional investors purchased a net $701.8 thousand shares of MDCO during the quarter ended September 2014 and now own 104.87% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SLATE PATH CAPITAL LP Bought 1.1 Million shares of Medicines Co
PARTNER FUND MANAGEMENT LP Bought 414.4 Thousand shares of Medicines Co
INVESCO POWERSHARES CAPITAL MANA... Bought 346.5 Thousand shares of Medicines Co